Sort
4,870 grants matching “glp 1”
Vascular CT contrast agent development
$843,622Michael A Davis · Nextrast, Inc. · R44 · FY2021 · HL
Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy
$841,919Lei Zhu · Migra-Therapeutics, Llc · R44 · FY2023 · CA
The Next-Generation Developmental and Reproductive Toxicology (DART) Assay using High-Content Analysis of Genetically Diverse C. elegans Populations
$841,749Evan Hegarty · Vivoverse, Llc · R44 · FY2024 · ES
Novel non-narcotic analgesic for acute and chronic pain
$840,427Nicolas Guillermo Bazan · South Rampart Pharma, Llc · R42 · FY2021 · NS
Novel non-narcotic analgesic for acute and chronic pain
$840,427Nicolas Guillermo Bazan · South Rampart Pharma, Llc · R42 · FY2022 · NS
Large animal therapy studies
$839,884William A. Beltran · University Of Pennsylvania · R24 · FY2012 · EY
Project 1 - Profectus Biosciences, Inc.
$839,059John H Eldridge · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2020 · AI
Targeting superbugs: discovery and development of new broad-spectrum lipopeptides
$838,537Jian Li · Monash University · R01 · FY2015 · AI
Appalachian Node
$838,320Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2025 · DA
Animal Medicine COVID Support
$837,751Ruth Woodward · National Institute Of Allergy And Infectious Diseases · ZIG · FY2021 · AI
Development of a potent and selective oral ENPP1 inhibitor for oncology
$836,231Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2023 · CA
Therapeutic Thrombin Analogs
$834,603Erik Ian Tucker · Aronora, Inc. · R44 · FY2014 · HL
Optimization of Lead BKIs for Cryptosporidiosis Therapy
$834,465Wesley C Van Voorhis · University Of Washington · R01 · FY2021 · AI
Glial Progenitor Cells for Treatment of ALS
$833,878Linda L Kelley · Johns Hopkins University · U01 · FY2010 · NS
The optimization of compounds that selectively inhibit protein synthesis for the
$833,819Cathy A Swindlehurst · Novomedix, Inc. · R44 · FY2013 · CA
Combination Therapy with Semaglutide and Anti-Amyloid Antibodies for Alzheimers Disease
$833,674Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2025 · AG
Pulmonary Valved Graft with Regeneration Potential for Pediatric Patients
$833,493Ajay Houde · Annoviant, Inc · R44 · FY2024 · HL
Long-acting ghrelin for the treatment of cancer cachexia
$832,924Tarik Soliman · Extend Biosciences, Inc. · R44 · FY2017 · CA
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
$832,900David A Ehrmann · University Of Chicago · U01 · FY2015 · DK
Manufacturing and Toxicology Studies of DNA and Protein Vaccines
$832,766Gary R Ostroff · Univ Of Massachusetts Med Sch Worcester · U19 · FY2011 · AI
Development of novel anti-biofilm compounds for treating chronic wounds
$832,651Daina Zeng · Agile Sciences, Inc. · R44 · FY2016 · AI
First-in-class TREM-1 inhibitors for neovascular retinal diseases
$830,491Alexander B Sigalov · Signablok, Inc. · R44 · FY2025 · EY
A Novel Peptide Therapeutic for Obesity
$829,401Neil A Fanger · Virtici, Llc · R44 · FY2018 · DK
Targeting superbugs: discovery and development of new broad-spectrum lipopeptides
$829,212Jian Li · Monash University · R01 · FY2014 · AI
Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
$829,097Brian F Volkman · Xlock Biosciences, Llc · R44 · FY2021 · AR